John Militello - Jul 20, 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: VP, Principal Accounting Officer and Interim Principal Financial Officer
Signature: /s/ Martin Wilson, as attorney-in-fact for John Militello
Stock symbol: RCKT
Transactions as of: Jul 20, 2023
Transactions value $: -$10,906
Form type: 4
Date filed: 7/24/2023, 04:05 PM
Previous filing: Jul 20, 2023
Next filing: Aug 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Sale	-$10.9K	-573	-7.44%	$19.03	7.13K	Jul 20, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Remarks:

VP, Principal Accounting Officer and Interim Principal Financial Officer